» Articles » PMID: 37473758

Excitatory Neuron-specific Suppression of the Integrated Stress Response Contributes to Autism-related Phenotypes in Fragile X Syndrome

Abstract

Dysregulation of protein synthesis is one of the key mechanisms underlying autism spectrum disorder (ASD). However, the role of a major pathway controlling protein synthesis, the integrated stress response (ISR), in ASD remains poorly understood. Here, we demonstrate that the main arm of the ISR, eIF2α phosphorylation (p-eIF2α), is suppressed in excitatory, but not inhibitory, neurons in a mouse model of fragile X syndrome (FXS; Fmr1). We further show that the decrease in p-eIF2α is mediated via activation of mTORC1. Genetic reduction of p-eIF2α only in excitatory neurons is sufficient to increase general protein synthesis and cause autism-like behavior. In Fmr1 mice, restoration of p-eIF2α solely in excitatory neurons reverses elevated protein synthesis and rescues autism-related phenotypes. Thus, we reveal a previously unknown causal relationship between excitatory neuron-specific translational control via the ISR pathway, general protein synthesis, and core phenotypes reminiscent of autism in a mouse model of FXS.

Citing Articles

Postnatal downregulation of Fmr1 in microglia promotes microglial reactivity and causes behavioural alterations in female mice.

Hooshmandi M, Ho-Tieng D, Lister K, Cai W, Wong C, Brown N Mol Autism. 2025; 16(1):17.

PMID: 40055803 PMC: 11887208. DOI: 10.1186/s13229-025-00648-2.


Novel p.Arg534del Mutation and MTHFR C667T Polymorphism in Fragile X Syndrome (FXS) With Autism Spectrum Phenotype: A Case Report.

Hasan H, Santos E, Amrei S, Tassone F, Randol J, Hagerman P Case Rep Genet. 2025; 2025:9751565.

PMID: 39839505 PMC: 11745553. DOI: 10.1155/crig/9751565.


The integrated stress response in brain diseases: A double-edged sword for proteostasis and synapses.

Lockshin E, Calakos N Curr Opin Neurobiol. 2024; 87:102886.

PMID: 38901329 PMC: 11646490. DOI: 10.1016/j.conb.2024.102886.


The integrated stress response pathway and neuromodulator signaling in the brain: lessons learned from dystonia.

Calakos N, Caffall Z J Clin Invest. 2024; 134(7).

PMID: 38557486 PMC: 10977992. DOI: 10.1172/JCI177833.


Translational modulator ISRIB alleviates synaptic and behavioral phenotypes in Fragile X syndrome.

Coulson R, Frattini V, Moyer C, Hodges J, Walter P, Mourrain P iScience. 2024; 27(4):109259.

PMID: 38510125 PMC: 10951902. DOI: 10.1016/j.isci.2024.109259.

References
1.
Huber K, Gallagher S, Warren S, Bear M . Altered synaptic plasticity in a mouse model of fragile X mental retardation. Proc Natl Acad Sci U S A. 2002; 99(11):7746-50. PMC: 124340. DOI: 10.1073/pnas.122205699. View

2.
Mientjes E, Nieuwenhuizen I, Kirkpatrick L, Zu T, Hoogeveen-Westerveld M, Severijnen L . The generation of a conditional Fmr1 knock out mouse model to study Fmrp function in vivo. Neurobiol Dis. 2005; 21(3):549-55. DOI: 10.1016/j.nbd.2005.08.019. View

3.
Liu S, Yuan J, Yue W, Bi Y, Shen X, Gao J . GCN2 deficiency protects against high fat diet induced hepatic steatosis and insulin resistance in mice. Biochim Biophys Acta Mol Basis Dis. 2018; 1864(10):3257-3267. DOI: 10.1016/j.bbadis.2018.07.012. View

4.
Bhattacharya A, Kaphzan H, Alvarez-Dieppa A, Murphy J, Pierre P, Klann E . Genetic removal of p70 S6 kinase 1 corrects molecular, synaptic, and behavioral phenotypes in fragile X syndrome mice. Neuron. 2012; 76(2):325-37. PMC: 3479445. DOI: 10.1016/j.neuron.2012.07.022. View

5.
Kato T, Pothula S, Liu R, Duman C, Terwilliger R, Vlasuk G . Sestrin modulator NV-5138 produces rapid antidepressant effects via direct mTORC1 activation. J Clin Invest. 2019; 129(6):2542-2554. PMC: 6546461. DOI: 10.1172/JCI126859. View